| PMID | Title | Journal | Publication Year | Author | View in RVdb |
|---|---|---|---|---|---|
| 37705731 | The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein. | Front Microbiol | 2023 | Piacentini S;Riccio A;Santopolo S;Pauciullo S;La Frazia S;Rossi A;Rossignol JF;Santoro MG | View More |